DELVE INTO AFRICAN WEALTH
DON'T MISS A BEAT
Subscribe now
Skip to content

African Wealth Briefing — Thurs., July 2, 2026

Johann Rupert's Remgro takes full control of Mediclinic in a $947 million deal. OCI's board backs Nassef Sawiris' bid to take the company private.

African Wealth Briefing — Thurs., July 2, 2026

Table of Contents

Good morning from Billionaires.Africa.

Here is a brief on what we published yesterday.

Wednesday belonged to consolidation — big owners moving to take full control of the assets they prize, from South African hospitals to a Dutch-listed chemicals giant.

The lead: Rupert takes Mediclinic

Johann Rupert's investment company, Remgro, completed a deal to take full control of Mediclinic's Southern Africa operations for $947 million, after the Competition Tribunal and all other regulators approved. For a portfolio built to compound quietly across decades, private hospitals are a quintessential Rupert asset — defensive, essential and cash-generative — and owning them outright rather than in partnership signals a tightening of Africa's most patient empire around its best businesses.

The take-private advances

North Africa — a board comes around. OCI Global's board formally recommended Nassef Sawiris' €4.10-per-share all-cash offer to take the chemicals group private, and agreed to put the proposed Orascom Construction merger to a shareholder vote. It is a decisive turn in the impasse we covered last week: Egypt's richest man is a large step closer to reclaiming full control of the company he built.

Deals across the desk

West Africa — the refinery's reach grows. The Republic of Congo's national oil company opened talks with Aliko Dangote's Lagos refinery on a strategic partnership to secure refined-product supply — another sign the refinery is reshaping fuel trade across the continent.

North Africa — building the grid. Hassan Allam Construction won a $560 million EPC contract to build Egypt's 1,000-MW West Minya solar plant with a 600-MWh battery system, one of the country's largest renewable-energy projects.

Also on the desk

East Africa — a media standoff. Rostam Aziz flew to Entebbe to meet General Muhoozi Kainerugaba personally as the shutdown of Nation Media Group's outlets dragged on, with the group's owners reported to have committed to "more patriotic journalism" to secure a reopening. The episode remains a live press-freedom concern, and we are reporting it as it develops.

Central Africa — from a fish stall. We profiled Sylvestre Ngouchinghe, who began selling frozen fish at a Yaoundé market in 1982 and built Congelcam into a ~$280 million empire that controls up to 80% of Cameroon's seafood market — an infrastructure story disguised as a fish story.

The takeaway

Wednesday was about control: Rupert buying his hospitals outright, Sawiris winning his board, Dangote extending his refinery's reach. The continent's most established fortunes spent the day not chasing new ventures but consolidating their grip on the ones they already have.

On the site

Behind the paywall — for paid members

Now live from yesterday's premium slate:


Billionaires.Africa — the world's premier source of news on Africa's billionaires and UHNWIs. Forward to a colleague.

Figures are point-in-time estimates from public sources including Forbes, Bloomberg, company disclosures and exchange filings, as of reporting; they change with markets and currencies and are not measures of liquid wealth. Editorial analysis, not investment, legal or tax advice. © 2026 Billionaires.Africa Inc.

The intelligence satisfies curiosity. The paid briefings satisfy strategy.

Every Monday, Elite subscribers receive an Investor Memo breaking down the deal, the structure and the positioning behind the week's most consequential African wealth story - the kind of analysis that doesn't appear anywhere else.

Twice a month, a Wealth Intelligence brief profiles a single billionaire's holdings, cash flows and expansion pipeline in detail no public source matches.

Executive ($25/mo): Daily newsletter + Deep-Dive Reports

Elite ($75/mo): Everything above + Investor Memos + Wealth Intelligence + Quarterly Analyst Briefings

Subscribe now

Latest